by Sam Davies / 22 August 2018 A Texan medical device company has received FDA approval for five new spinal implants 3D printed in titanium. The family of five FDA 510(k)-cleared lumbar interbody fusion devices is being brought to market by Osseus Fusion Systems under the brand name, Aries. Osseus has been working to develop advanced technology products to enable minimally invasive surgery since it
August 21, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced that the Methodist Dallas Medical Center installed an EOS® system for low-dose, 2D/3D imaging of adult and pediatric patients. The installation marks the 100th system installed in the
SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, is pleased to announce the successful completion of the first spine fusion surgery using the Valeo C+CSC with Lumen Interbody Fusion Device. The first surgery was performed by Dr.
August 16, 2018 ST. LOUIS--(BUSINESS WIRE)--CoreLink, LLC, a vertically integrated manufacturer of spinal implant systems, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market The FoundationTM 3D Anterior Lumbar (ALIF) Interbody device. This marks the launch of the latest addition to CoreLink’s Foundation 3D Interbody Cage family. Jay Bartling, CEO, said,
SAN DIEGO, Aug. 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Dale Wolf as vice president, Manufacturing, who will oversee the Company's West Carrollton, Ohio manufacturing facility. Mr. Wolf will fill a newly created role emphasizing the importance of the company's
THORNTON CLEVELEYS, ENGLAND (PRWEB) AUGUST 14, 2018 The growing interest in PEEK-OPTIMA™ spinal implants in China received further impetus at the 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership with the North American Spine Society (NASS). At this event, Fule Science & Technology Development, Beijing, and Invibio Biomaterial Solutions partnered to demonstrate the new
CHICAGO, Aug. 14, 2018 /PRNewswire/ -- U. S. News & World Report released its 2018-2019 Best Hospitals National Ranking and the Department of Orthopaedic Surgery at Rush University Medical Center (RUMC), consisting of Midwest Orthopaedics at Rush (MOR) physicians, moved from the fifth to the fourth best orthopedic program in the nation. The report also continues to honor RUMC/MOR as the highest ranked orthopedic program in Illinois. "We
FLOWOOD, Miss., Aug. 14, 2018 /PRNewswire/ -- Zavation, an employee-owned medical device company that designs, develops, manufactures and distributes medical device products, announced today the launch of a fenestrated Facet Screw system and a Sacroiliac (SI) Screw system. For more information on Zavation's complete product portfolio, visit http://zavation.com/. The Zavation Facet Screw system is a permanent implant device made from
SAN DIEGO and ERLANGEN, Germany, Aug. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) and Siemens Healthineers today announced a strategic partnership focused on technology development, marketing and commercial activities to advance clinical outcomes in minimally invasive spine surgery. NuVasive is an innovation leader in spine health technology, focused on transforming spine surgery with minimally disruptive, predictable and clinically reproducible procedurally-integrated solutions,
August 08, 2018 YOKNEAM, Israel--(BUSINESS WIRE)--Augmedics has begun a first-in-human clinical trial of its xvision-spine (XVS) augmented-reality surgical navigation system at Sheba Tel Hashomer Medical Center and Asaf Harofeh Medical Center, in Israel. Led by Co-Principal Investigators Dr. Ran Harel and Prof. Yigal Mirovsky, the open label, prospective, single arm, multi-center study will evaluate the safety,
